About this trial
This study aims to evaluate the efficacy of doxycycline treating Thyroid Associated Ophthalmopathy by multi-modal image.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Informed consent
Age 18-70 years old
Diagnosed with TAO
Disqualifiers
Sight-threatening TAO with dysthyroid optic neuropathy
Allergy of tetracycline
Have contraindications of MRI(metal pacemaker, fake teeth, foreign body and other materials which will disturb the examination)
Trial design
Single group
Treatments tested in this trial
Doxycycline Hyclate
Drugpatients administrated with doxycycline tablets 100mg orally per day
Treatment groups
Trial outcomes
Primary outcomes
change of extraocular muscle volume and orbital fat volume by MRI
3D MRI image will be established and the volume of extraocular muscle and orbital fat will be calculated by the same advanced programmer who is blinded of the pre- or post- treatment images order. A higher score means a better outcome.
Secondary outcomes
change of exophthalmos
exophthalmos will be measured by the same investigator using the same Hertel instrument. A higher change of exphthalmos means a better outcome.
change of Quality of Life
The score of quality of life will be assessed by the same investigator using GO-QoL. The better change of quality of life means a better outcome.
change of eyelid aperture, lid retraction and lid lag
the values will be measured by the same investigator using the same millimeter ruler and the higher values change, the better the outcome is.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.